Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - lyophilized powder for injection - coagulation factor ix recombinant-rfix 1000 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - lyophilized powder for injection - coagulation factor ix recombinant-rfix 2000 iu - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 800 iu/10 ml - antihemophilic factor (human) (factor viii) min 800 iu/10 ml

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 250 iu/5 ml - antihemophilic factor (human) (factor viii) min 250 iu/5 ml

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 400 iu/5 ml - antihemophilic factor (human) (factor viii) min 400 iu/5 ml

Canada - English - Health Canada

grifols biologicals llc - von willebrand factor (human); antihemophilic factor (human) - powder for solution - 300unit; 250unit - von willebrand factor (human) 300unit; antihemophilic factor (human) 250unit - hemostatics

Canada - English - Health Canada

grifols biologicals llc - von willebrand factor (human); antihemophilic factor (human) - powder for solution - 600unit; 500unit - von willebrand factor (human) 600unit; antihemophilic factor (human) 500unit - hemostatics

Canada - English - Health Canada

grifols biologicals llc - von willebrand factor (human); antihemophilic factor (human) - powder for solution - 1200unit; 1000unit - von willebrand factor (human) 1200unit; antihemophilic factor (human) 1000unit - hemostatics

Canada - English - Health Canada

grifols biologicals llc - von willebrand factor (human); antihemophilic factor (human) - powder for solution - 1800unit; 1500unit - von willebrand factor (human) 1800unit; antihemophilic factor (human) 1500unit - hemostatics

Canada - English - Health Canada

grifols biologicals llc - von willebrand factor (human); antihemophilic factor (human) - powder for solution - 2400unit; 2000unit - von willebrand factor (human) 2400unit; antihemophilic factor (human) 2000unit - hemostatics